Biotron Limited is at the forefront of innovative therapeutic solutions targeting severe viral infections, including HIV and Hepatitis C. Committed to advancing biotechnology and pharmaceuticals, the company leverages cutting-edge research to develop transformative treatments in the life sciences sector.